557 related articles for article (PubMed ID: 10614629)
1. Somatostatin inhibits insulin and glucagon secretion via two receptors subtypes: an in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice.
Strowski MZ; Parmar RM; Blake AD; Schaeffer JM
Endocrinology; 2000 Jan; 141(1):111-7. PubMed ID: 10614629
[TBL] [Abstract][Full Text] [Related]
2. Characterization of somatostatin receptor subtype-specific regulation of insulin and glucagon secretion: an in vitro study on isolated human pancreatic islets.
Singh V; Brendel MD; Zacharias S; Mergler S; Jahr H; Wiedenmann B; Bretzel RG; Plöckinger U; Strowski MZ
J Clin Endocrinol Metab; 2007 Feb; 92(2):673-80. PubMed ID: 17105845
[TBL] [Abstract][Full Text] [Related]
3. Antidiabetic activity of a highly potent and selective nonpeptide somatostatin receptor subtype-2 agonist.
Strowski MZ; Cashen DE; Birzin ET; Yang L; Singh V; Jacks TM; Nowak KW; Rohrer SP; Patchett AA; Smith RG; Schaeffer JM
Endocrinology; 2006 Oct; 147(10):4664-73. PubMed ID: 16857751
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin receptor subtype 5 regulates insulin secretion and glucose homeostasis.
Strowski MZ; Kohler M; Chen HY; Trumbauer ME; Li Z; Szalkowski D; Gopal-Truter S; Fisher JK; Schaeffer JM; Blake AD; Zhang BB; Wilkinson HA
Mol Endocrinol; 2003 Jan; 17(1):93-106. PubMed ID: 12511609
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin inhibits insulin release via SSTR2 in hamster clonal beta-cells and pancreatic islets.
Yao CY; Gill M; Martens CA; Coy DH; Hsu WH
Regul Pept; 2005 Jul; 129(1-3):79-84. PubMed ID: 15927701
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of human pancreatic islet insulin release by receptor-selective somatostatin analogs directed to somatostatin receptor subtype 5.
Zambre Y; Ling Z; Chen MC; Hou X; Woon CW; Culler M; Taylor JE; Coy DH; Van Schravendijk C; Schuit F; Pipeleers DG; Eizirik DL
Biochem Pharmacol; 1999 May; 57(10):1159-64. PubMed ID: 11230804
[TBL] [Abstract][Full Text] [Related]
7. Intra-islet somatostatin regulates glucagon release via type 2 somatostatin receptors in rats.
Cejvan K; Coy DH; Efendic S
Diabetes; 2003 May; 52(5):1176-81. PubMed ID: 12716749
[TBL] [Abstract][Full Text] [Related]
8. SSTR2 is the functionally dominant somatostatin receptor in human pancreatic β- and α-cells.
Kailey B; van de Bunt M; Cheley S; Johnson PR; MacDonald PE; Gloyn AL; Rorsman P; Braun M
Am J Physiol Endocrinol Metab; 2012 Nov; 303(9):E1107-16. PubMed ID: 22932785
[TBL] [Abstract][Full Text] [Related]
9. Double-gene ablation of SSTR1 and SSTR5 results in hyperinsulinemia and improved glucose tolerance in mice.
Wang XP; Norman MA; Yang J; Cheung A; Moldovan S; Demayo FJ; Brunicardi FC
Surgery; 2004 Sep; 136(3):585-92. PubMed ID: 15349106
[TBL] [Abstract][Full Text] [Related]
10. SSTR2 mediates the somatostatin-induced increase in intracellular Ca(2+) concentration and insulin secretion in the presence of arginine vasopressin in clonal beta-cell HIT-T15.
Cheng H; Yibchok-anun S; Coy DH; Hsu WH
Life Sci; 2002 Jul; 71(8):927-36. PubMed ID: 12084389
[TBL] [Abstract][Full Text] [Related]
11. Specific inhibition of rat pancreatic insulin or glucagon release by receptor-selective somatostatin analogs.
Rossowski WJ; Coy DH
Biochem Biophys Res Commun; 1994 Nov; 205(1):341-6. PubMed ID: 7999046
[TBL] [Abstract][Full Text] [Related]
12. Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis.
Kumar U; Sasi R; Suresh S; Patel A; Thangaraju M; Metrakos P; Patel SC; Patel YC
Diabetes; 1999 Jan; 48(1):77-85. PubMed ID: 9892225
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of somatostatin (SST) receptor type 5 (SSTR5) is associated with sexually dimorphic changes in the expression of SST and SST receptors in brain and pancreas.
Ramírez JL; Grant M; Norman M; Wang XP; Moldovan S; de Mayo FJ; Brunicardi C; Kumar U
Mol Cell Endocrinol; 2004 Jun; 221(1-2):105-19. PubMed ID: 15223137
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of subtype selective somatostatin receptor agonists.
Rohrer SP; Schaeffer JM
J Physiol Paris; 2000; 94(3-4):211-5. PubMed ID: 11087999
[TBL] [Abstract][Full Text] [Related]
15. The somatostatin receptor in human pancreatic β-cells.
Braun M
Vitam Horm; 2014; 95():165-93. PubMed ID: 24559918
[TBL] [Abstract][Full Text] [Related]
16. A role for islet somatostatin in mediating sympathetic regulation of glucagon secretion.
Hauge-Evans AC; King AJ; Fairhall K; Persaud SJ; Jones PM
Islets; 2010; 2(6):341-4. PubMed ID: 21099335
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin stimulates ductal bile absorption and inhibits ductal bile secretion in mice via SSTR2 on cholangiocytes.
Gong AY; Tietz PS; Muff MA; Splinter PL; Huebert RC; Strowski MZ; Chen XM; LaRusso NF
Am J Physiol Cell Physiol; 2003 May; 284(5):C1205-14. PubMed ID: 12676656
[TBL] [Abstract][Full Text] [Related]
18. The effect of global SSTR5 gene ablation on the endocrine pancreas and glucose regulation in aging mice.
Wang XP; Norman M; Yang J; Liu SH; Magnusson J; DeMayo FJ; Brunicardi FC
J Surg Res; 2005 Nov; 129(1):64-72. PubMed ID: 16026801
[TBL] [Abstract][Full Text] [Related]
19. Nonpeptidyl somatostatin agonists demonstrate that sst2 and sst5 inhibit stimulated growth hormone secretion from rat anterior pituitary cells.
Parmar RM; Chan WW; Dashkevicz M; Hayes EC; Rohrer SP; Smith RG; Schaeffer JM; Blake AD
Biochem Biophys Res Commun; 1999 Sep; 263(2):276-80. PubMed ID: 10491284
[TBL] [Abstract][Full Text] [Related]
20. Paracrine regulation of somatostatin secretion by insulin and glucagon in mouse pancreatic islets.
Svendsen B; Holst JJ
Diabetologia; 2021 Jan; 64(1):142-151. PubMed ID: 33043402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
